Elissa spent the past 12 years launching specialty therapeutics and initiatives in the bio-pharmaceutical industry and developing economic policy in the public sector. She most recently lead patient strategy and digital innovation for biosimilar immunology products at Merck, brought their ground-breaking immunotherapy cancer treatment to market and developed their first 24/7 patient support program. Elissa earned her MBA as a Woodruff Fellow at Emory University and her B.A. from Cornell University.
Traditional financing approaches have held back the task of manufacturing and distributing COVID-19 mRNA vaccines, a process which required advanced facilities and new distribution pathwa...
On 16 March 2020, the first ‘mRNA’ vaccine designed to fend off the SARS-CoV-2 virus was injected into Jennifer Haller in Seattle. This date marked the beginning of human clinical trials ...
This week the World Economic Forum is hosting the Global Technology Governance Summit, which aims to be the foremost global multi-stakeholder gathering dedicated to the responsible design...
Since early 2020, health systems around the globe have marshalled a response to the nearly unrelenting demands of the COVID-19 pandemic. Other diseases and health needs have not stopped, ...
The world has arrived at a precarious juncture in the COVID-19 pandemic. The initial roll-out of vaccines has begun in a few countries, but infections and deaths are still rising globally...
The disproportionately devastating impact of the COVID-19 pandemic on minority communities is alarming. Data from government offices in both the United States and United Kingdom show high...
As several companies race to develop a coronavirus vaccine, the public is repeatedly reminded that the finish line is at least 12 to 18 months away. This timeline feels excruciatingly lon...
What will health ministers and thought leaders gathering for the 72nd Annual World Health Assembly (WHA) imagine for the future of global healthcare in 2030?
Aujourd'hui, les Africains sont plus nombreux à mourir du cancer que du paludisme. Comme la plupart des autres pays du monde, de nombreux pays africains sont confrontés à des taux croissa...
En la actualidad, mueren más africanos de cáncer que de malaria. Como la mayoría de las otras naciones en el mundo, muchos países africanos están luchando contra el aumento de las tasas d...
More Africans are now dying from cancer than from malaria. Like most other nations in the world, many African countries are contending with rising rates of non-communicable diseases (NCDs...
A 53-year-old woman - let’s call her Alice - comes to her doctor’s office with pain, aching, and masses in her abdomen. The doctor suspects cancer but cannot be sure. Normally, the doctor...
